Home › NDC Lookup › RxCUI directory › RxCUI 1598470

Benzoyl peroxide 0.0375 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel — RxCUI 1598470

RxNorm drug concept · Semantic clinical drug
RxCUI 1598470 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1598470
Official nameBenzoyl peroxide 0.0375 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbenzoyl peroxide 3.75 % / clindamycin phosphate 1.2 % (clindamycin 1 % ) Topical Gel; clindamycin phosphate 1.2 % / benzoyl peroxide 3.75 % Topical Gel
FDA products mapped5
Package NDCs mapped6
Reported Medicaid activity (SDUD)6,540 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Benzoyl Peroxide Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Benzoyl peroxide is most commonly used to treat acne — products like Oxy 10 and PanOxyl are available over the counter for this purpose. EPSOLAY, a prescription cream version, is s...
  • What exactly is benzoyl peroxide used for?
  • Yes, that's very common, especially when you're just starting out. Benzoyl peroxide can cause dryness, redness, peeling, and some burning or stinging. The best approach is to start...
  • My skin got really dry and red after I started using it — is that normal?
📖 Read our full Benzoyl Peroxide Topical guide →

🕸️ Concept Web — How Benzoyl peroxide 0.0375 MG/MG / clindamycin phos... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benzoyl peroxide 0.0375 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel RxCUI 1598470

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Benzoyl peroxide 1418
    • Clindamycin 2582
    • Benzoyl peroxide / clindamycin 646781
    • Clindamycin phosphate 797272
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Onexton 1598820
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzoyl peroxide / clindamycin Topical Gel 379074
    • Benzoyl peroxide / clindamycin phosphate Topical Gel 2647031
    • Benzoyl peroxide / clindamycin Topical Product 1152978
    • Benzoyl peroxide / clindamycin phosphate Topical Product 2662222
    • Benzoyl peroxide / clindamycin Topical Gel [Onexton] 1598822
    • Benzoyl peroxide / clindamycin phosphate Topical Gel [Onexton] 2657807
    • Onexton Topical Product 1598823
    • Topical Gel 346286
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benzoyl peroxide 0.0375 MG/MG SCDC · 1598469
  • Clindamycin phosphate 0.012 MG/MG SCDC · 882547
  • Benzoyl peroxide / clindamycin Topical Gel SCDF · 379074
  • Benzoyl peroxide / clindamycin phosphate Topical Gel SCDFP · 2647031
  • Benzoyl peroxide / clindamycin Topical Product SCDG · 1152978
  • Benzoyl peroxide / clindamycin phosphate Topical Product SCDGP · 2662222

Brand-Name Concepts

📦 FDA Products & Package NDCs

5 products · 6 package NDCs
6 package NDCs map to RxCUI 1598470 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-3050-35 3.5 g in 1 TUBE (0187-3050-35) ONEXTON Bausch Health US, LLC 2014-11-24
00187-3050-50 1 BOTTLE, PUMP in 1 CARTON (0187-3050-50) / 50 g in 1 BOTTL... ONEXTON Bausch Health US, LLC 2014-11-24
45802-0383-01 50 g in 1 BOTTLE, PUMP (45802-383-01) Clindamycin Phosphate and Benzoyl Peroxide Padagis Israel Pharmaceuticals Ltd 2024-09-20
68308-0127-50 50 g in 1 BOTTLE, PUMP (68308-127-50) Clindamycin Phosphate and Benzoyl Peroxide Mayne Pharma 2025-10-01
68682-0133-50 1 BOTTLE, PUMP in 1 CARTON (68682-133-50) / 50 g in 1 BOTTL... Clindamycin Phosphate and Benzoyl Peroxide Oceanside Pharmaceuticals 2023-10-02
72162-2419-02 50 g in 1 BOTTLE, PUMP (72162-2419-2) Clindamycin Phosphate and Benzoyl Peroxide Bryant Ranch Prepack 2024-11-11
Observed labelers: Bausch Health US, LLC (2) · Bryant Ranch Prepack (1) · Mayne Pharma (1) · Oceanside Pharmaceuticals (1) · Padagis Israel Pharmaceuticals Ltd (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$2.3829
Range $2.3829–$2.3829 · middle 50% $2.3829–$2.3829 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.